Overview
Hereditary neuropathy with liability to pressure palsies (HNPP), also known as tomaculous neuropathy or hereditary pressure-sensitive neuropathy, is a genetic disorder affecting the peripheral nervous system. It is caused by a deletion or, less commonly, a point mutation in the PMP22 gene on chromosome 17p11.2, which encodes peripheral myelin protein 22. This protein is essential for the formation and maintenance of myelin, the insulating sheath that surrounds peripheral nerves. The loss of one functional copy of PMP22 leads to abnormally formed myelin, making nerves unusually susceptible to damage from mechanical stress such as compression, stretching, or repetitive movements. Patients with HNPP typically experience recurrent episodes of numbness, tingling, muscle weakness, and sometimes pain in areas where peripheral nerves are vulnerable to compression — such as the wrists (carpal tunnel), elbows (ulnar nerve), and knees (peroneal nerve). These episodes, often called pressure palsies, are usually triggered by activities that would not cause problems in unaffected individuals, such as leaning on the elbows, crossing the legs, or carrying heavy bags. Episodes may last days to months and often resolve partially or completely, though over time some patients develop a mild chronic peripheral neuropathy with persistent weakness or sensory loss. Nerve conduction studies typically show diffusely slowed conduction velocities and focal conduction abnormalities at common entrapment sites. Nerve biopsy characteristically reveals focal thickenings of the myelin sheath called tomacula. There is currently no cure or disease-modifying treatment for HNPP. Management focuses on prevention and supportive care. Patients are advised to avoid prolonged pressure on nerves, repetitive movements, and sustained postures that compress vulnerable nerve sites. Protective padding (e.g., elbow or wrist pads) and ergonomic modifications may help reduce episodes. Physical and occupational therapy can assist with rehabilitation after episodes. In some cases, surgical decompression of entrapped nerves may be considered, though outcomes can be variable. Genetic counseling is recommended for affected individuals and their families.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Hereditary neuropathy with liability to pressure palsies.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hereditary neuropathy with liability to pressure palsies at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hereditary neuropathy with liability to pressure palsies.
Community
No community posts yet. Be the first to share your experience with Hereditary neuropathy with liability to pressure palsies.
Start the conversation →Latest news about Hereditary neuropathy with liability to pressure palsies
No recent news articles for Hereditary neuropathy with liability to pressure palsies.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hereditary neuropathy with liability to pressure palsies
What is Hereditary neuropathy with liability to pressure palsies?
Hereditary neuropathy with liability to pressure palsies (HNPP), also known as tomaculous neuropathy or hereditary pressure-sensitive neuropathy, is a genetic disorder affecting the peripheral nervous system. It is caused by a deletion or, less commonly, a point mutation in the PMP22 gene on chromosome 17p11.2, which encodes peripheral myelin protein 22. This protein is essential for the formation and maintenance of myelin, the insulating sheath that surrounds peripheral nerves. The loss of one functional copy of PMP22 leads to abnormally formed myelin, making nerves unusually susceptible to d
How is Hereditary neuropathy with liability to pressure palsies inherited?
Hereditary neuropathy with liability to pressure palsies follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Hereditary neuropathy with liability to pressure palsies?
25 specialists and care centers treating Hereditary neuropathy with liability to pressure palsies are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.